Bloodstream Infection Clinical Trial
Official title:
Chlorhexidine Containing Iv-securement Dressings for the Prevention of Central Venous Catheter-related Blood Stream Infections in Neutropenic Patients: a Randomized Trial
In neutropenic cancer patients, catheter-related bloodstream infections may cause severe infections and even death. To assess the prophylactic effect of a chlorhexidine coated catheter securement dressing on the incidence of catheter-related bloodstream infections, this open, randomized trial is being carried out. CHG iv Tegaderm securement dressing will be randomized in a 1:1 fashion against Tegaderm Advanced iv securement dressing.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
| Completed |
NCT02400268 -
Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae
|
Phase 3 | |
| Recruiting |
NCT04070820 -
Combination Treatment for Enterococcus Faecalis Bacteriemia Multicenter, Observational Study"
|
||
| Completed |
NCT03147807 -
BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU
|
N/A | |
| Completed |
NCT05411315 -
Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment
|
N/A | |
| Enrolling by invitation |
NCT05880069 -
Clinical Outcomes in Patients With Infection by Resistant Microorganism
|
||
| Terminated |
NCT04250168 -
Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response
|
||
| Terminated |
NCT04876430 -
Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
|
Phase 2/Phase 3 | |
| Completed |
NCT03255759 -
Actionable Results: Bloodstream Infection Molecular Assay Evaluation
|
N/A | |
| Active, not recruiting |
NCT03744728 -
Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures
|
N/A | |
| Terminated |
NCT00680459 -
Ethanol Locks for the Treatment of Central Venous Line Infections
|
Phase 3 | |
| Recruiting |
NCT04839653 -
Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria
|
N/A | |
| Recruiting |
NCT03896893 -
Neonatal Bacterial Colonization Study
|
N/A | |
| Completed |
NCT05277350 -
A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT00843804 -
Surveillance for Nosocomial Infections in Pediatric Cancer Patients
|
N/A | |
| Completed |
NCT00467272 -
Catheter Related - Gram Positive Bloodstream Infections
|
Phase 2 | |
| Recruiting |
NCT04658017 -
GARNET™ Filter (GARNET Device) IDE Used in Chronic Hemodialysis Patients With a Bloodstream Infection
|
N/A | |
| Completed |
NCT04710212 -
Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies
|
||
| Not yet recruiting |
NCT06271031 -
Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection
|
||
| Not yet recruiting |
NCT03991793 -
Granzyme A in Patients With E. Coli Bacteremic Urinary Tract Infections
|